Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Myocyte enhancer factor 2C in hematopoiesis and leukemia
K. Canté-Barrett
,
R. Pieters
, J. P.P. Meijerink
Research output
:
Contribution to journal
›
Review article
›
peer-review
76
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Myocyte enhancer factor 2C in hematopoiesis and leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Leukemia
100%
Enhancer Region
100%
Hematopoiesis
100%
Muscle Cell
100%
Acute Lymphoblastic Leukemia
25%
Transcription Factors
25%
Acute Myeloid Leukemia
25%
Hematological System
25%
Ectopic Expression
25%
Muscle Development
25%
Keyphrases
Leukemia
100%
Hematopoiesis
100%
Myocyte Enhancer Factor 2C (MEF2C)
100%
Transcription Factor
16%
Acute Myeloid Leukemia
16%
Ectopic Expression
16%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Hematopoietic System
16%
Chromosomal Rearrangements
16%
Mixed-phenotype Acute Leukemia
16%
Human Leukemia
16%
Transcriptional Complex
16%
Muscle Development
16%
Biochemistry, Genetics and Molecular Biology
Enhancer Region
100%
Hematopoiesis
100%
MEF2C
100%
T Cell
20%
Transcription Factors
20%
Myeloid
20%
Ectopic Expression
20%
Chromosomal Rearrangement
20%
Myogenesis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Acute Lymphoblastic Leukemia
25%
Transcription Factors
25%
Acute Myeloid Leukemia
25%